Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285384730> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4285384730 endingPage "676" @default.
- W4285384730 startingPage "674" @default.
- W4285384730 abstract "For many years, cerebral amyloid angiopathy (CAA), which is an important cause of intracerebral haemorrhage in older people, was diagnosed on the basis of pathology, by the presence of amyloid-β protein deposition in small and medium arteries and capillaries within the cortex and leptomeninges. Publication of the Boston criteria for CAA allowed an imaging-based clinical diagnosis of probable CAA to be made without the need for brain tissue. 1 Greenberg SM Briggs ME Hyman BT et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke. 1996; 27: 1333-1337 Crossref PubMed Scopus (216) Google Scholar As knowledge in the field accrued and imaging techniques improved, the criteria were updated in 2010 (modified Boston criteria) 2 Leurent C Goodman JA Zhang Y et al. Immunotherapy with ponezumab for probable cerebral amyloid angiopathy. Ann Clin Transl Neurol. 2019; 6: 795-806 Crossref PubMed Scopus (26) Google Scholar to allow inclusion of cortical superficial siderosis as an additional haemorrhagic lesion, which improved their sensitivity. The Boston criteria have been influential in research (by increasing interest in CAA internationally and providing the diagnostic framework for clinical trials) and useful in clinical practice (by aiding clinicians and patients to make better informed decisions, for example for patients who have atrial fibrillation and meet criteria for possible or probable CAA, and so have an increased risk of intracerebral haemorrhage). 3 DeSimone CV Graff-Radford J El-Harasis MA Rabinstein AA Asirvatham SJ Holmes Jr, DR Cerebral amyloid angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation. J Am Coll Cardiol. 2017; 70: 1173-1182 Crossref PubMed Scopus (50) Google Scholar The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy studyThe Boston criteria v2.0 incorporate emerging MRI markers of CAA to enhance sensitivity without compromising their specificity in our cohorts of patients aged 50 years and older presenting with spontaneous intracerebral haemorrhage, cognitive impairment, or transient focal neurological episodes. Future studies will be needed to determine generalisability of the v.2.0 criteria across the full range of patients and clinical presentations. Full-Text PDF" @default.
- W4285384730 created "2022-07-14" @default.
- W4285384730 creator A5005572080 @default.
- W4285384730 creator A5031713672 @default.
- W4285384730 date "2022-08-01" @default.
- W4285384730 modified "2023-09-24" @default.
- W4285384730 title "Cerebral amyloid angiopathy criteria: the next generation" @default.
- W4285384730 cites W2166148093 @default.
- W4285384730 cites W2169851819 @default.
- W4285384730 cites W2321488910 @default.
- W4285384730 cites W2590987049 @default.
- W4285384730 cites W2748388100 @default.
- W4285384730 cites W2798054687 @default.
- W4285384730 cites W2922465750 @default.
- W4285384730 cites W4285384968 @default.
- W4285384730 doi "https://doi.org/10.1016/s1474-4422(22)00259-9" @default.
- W4285384730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35841897" @default.
- W4285384730 hasPublicationYear "2022" @default.
- W4285384730 type Work @default.
- W4285384730 citedByCount "0" @default.
- W4285384730 crossrefType "journal-article" @default.
- W4285384730 hasAuthorship W4285384730A5005572080 @default.
- W4285384730 hasAuthorship W4285384730A5031713672 @default.
- W4285384730 hasConcept C126322002 @default.
- W4285384730 hasConcept C142724271 @default.
- W4285384730 hasConcept C2777790613 @default.
- W4285384730 hasConcept C2779134260 @default.
- W4285384730 hasConcept C2779483572 @default.
- W4285384730 hasConcept C2780860705 @default.
- W4285384730 hasConcept C2910351856 @default.
- W4285384730 hasConcept C529278444 @default.
- W4285384730 hasConcept C71924100 @default.
- W4285384730 hasConceptScore W4285384730C126322002 @default.
- W4285384730 hasConceptScore W4285384730C142724271 @default.
- W4285384730 hasConceptScore W4285384730C2777790613 @default.
- W4285384730 hasConceptScore W4285384730C2779134260 @default.
- W4285384730 hasConceptScore W4285384730C2779483572 @default.
- W4285384730 hasConceptScore W4285384730C2780860705 @default.
- W4285384730 hasConceptScore W4285384730C2910351856 @default.
- W4285384730 hasConceptScore W4285384730C529278444 @default.
- W4285384730 hasConceptScore W4285384730C71924100 @default.
- W4285384730 hasFunder F4320337337 @default.
- W4285384730 hasIssue "8" @default.
- W4285384730 hasLocation W42853847301 @default.
- W4285384730 hasLocation W42853847302 @default.
- W4285384730 hasOpenAccess W4285384730 @default.
- W4285384730 hasPrimaryLocation W42853847301 @default.
- W4285384730 hasRelatedWork W1993973315 @default.
- W4285384730 hasRelatedWork W1999270353 @default.
- W4285384730 hasRelatedWork W2005608496 @default.
- W4285384730 hasRelatedWork W2166734331 @default.
- W4285384730 hasRelatedWork W2325420057 @default.
- W4285384730 hasRelatedWork W3087276809 @default.
- W4285384730 hasRelatedWork W3153842616 @default.
- W4285384730 hasRelatedWork W4210357711 @default.
- W4285384730 hasRelatedWork W4285384730 @default.
- W4285384730 hasRelatedWork W2579483139 @default.
- W4285384730 hasVolume "21" @default.
- W4285384730 isParatext "false" @default.
- W4285384730 isRetracted "false" @default.
- W4285384730 workType "article" @default.